Dilapan-S/Dilasoft E-Registry in Induction of Labor

Summary

International Observational E-Registry on the use of DILAPAN-S® osmotic dilator / DILASOFT® osmotic dilator for cervical ripening prior to labour induction.

Conditions

• Labour Onset and Length Abnormalities
• Labor; Forced or Induced, Affecting Fetus or Newborn

Interventions

DEVICE

Dilapan-S

Synthetic osmotic dilators Dilapan-S, Dilasoft for cervical ripening prior to induction of labor in women with unfavourable cervix

Sponsors & Collaborators

• Medicem International CR s.r.o.

  lead INDUSTRY

Principal Investigators

• Lars Hellmeyer, Doz, MD · Vivantes Klinikum im Friedrichshain, Berlin, Germany

• Franz Bahlman, Doz, MD · Buerger Hospital, Frankfurt am Main, Germany

• Janesh Gupta, MD, FRCOG · Birmingham Women´s Hospital, Birmingham, UK

• Petr Janku, MD · Masaryk University Hospital, Brno, Czech Republic

• Jozef Zahumensky, Doc, MD · University Hospital, Trnava, Slovakia

• Oleg Baev, MD, PhD · Federal State Budget Institution "Research Center for Obstetrics, Gynecology and Perinatology" of the Ministry of Healthcare of Russian Federation, Moscow, RUS

• Antonio Saad, MD, PhD · University of Texas Medical Branch Galveston, TX, US

• Amitasrigowri Murthy, MD, PhD · Bellevue Hospital, New York City, NY, US

• Amita Suneja, Prof, MD · Guru Teg Bahadur Hospital, New Delhi, India

• Usha Vishwanath, MD · Sri Ramachandra Medical Center, Chennai, India

• Anisha Gala, MD · Fernandez Hospital, Hyderabad, India

Eligibility

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2015-05-31

Primary Completion

2016-12-31

Completion

2016-12-31

Countries

• United States
• Czechia
• Germany
• India
• Russia
• Slovakia
• United Kingdom

Study Locations